A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.
Garey, Kevin W.; Ghantoji, Shashank S.; Shah, Dhara N.; Habib, Musarat; Arora, Vaneet; Jiang, Zhi-Dong; DuPont, Herbert L.; Journal of Antimicrobial Chemotherapy (JAC), 2011, vol. 66, issue 12, p 2850, ISSN 03057453. ISBN 14602091.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef